Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Non Operating Income (2020 - 2023)

Historic Non Operating Income for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to $2.3 million.

  • Therapeutics' Non Operating Income rose 5817.57% to $2.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.3 million, marking a year-over-year increase of 42447.62%. This contributed to the annual value of $10.3 million for FY2023, which is 42447.62% up from last year.
  • As of Q4 2023, Therapeutics' Non Operating Income stood at $2.3 million, which was up 5817.57% from $2.5 million recorded in Q3 2023.
  • Therapeutics' 5-year Non Operating Income high stood at $3.1 million for Q2 2023, and its period low was -$275000.0 during Q2 2022.
  • For the 4-year period, Therapeutics' Non Operating Income averaged around $846125.0, with its median value being $350000.0 (2020).
  • Over the last 5 years, Therapeutics' Non Operating Income had its largest YoY gain of 130952.38% in 2022, and its largest YoY loss of 84827.59% in 2022.
  • Over the past 4 years, Therapeutics' Non Operating Income (Quarter) stood at $549000.0 in 2020, then crashed by 80.87% to $105000.0 in 2021, then soared by 1309.52% to $1.5 million in 2022, then surged by 58.18% to $2.3 million in 2023.
  • Its last three reported values are $2.3 million in Q4 2023, $2.5 million for Q3 2023, and $3.1 million during Q2 2023.